L-Dopa in the treatment of Parkinson's disease.
D000203:Activities of Daily Living; D000368:Aged; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage* / Q000009:adverse effects; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D010300:Parkinson Disease / Q000188:drug therapy*; D013997:Time Factors; D014839:Vomiting / Q000139:chemically induced
D004295:Dihydroxyphenylalanine